Patent Assignment
Reel/Frame 052161/0645
Change of Address
Recorded: 2020-03-12
Pages: 2
Assignor
RESVERLOGIX CORP.
Executed: 2018-06-05
Assignee
RESVERLOGIX CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Properties
(2)
Novel Anti-Inflammatory Agents
Application:
15/668,542 →
Publication:
US 2017/0326143
Novel Anti-Inflammatory Agents
Application:
16/441,793 →
Publication:
US 2020/0129512
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jun 14, 2018
From: RESVERLOGIX CORP.
To: THIRD EYE CAPITAL CORPORATION
Reel/Frame 046090/0103 →
Security Interest
Sep 27, 2019
From: RESVERLOGIX CORP.
To: VISION LEADER LIMITED
Reel/Frame 050518/0714 →
Release of Security Interest
Oct 17, 2019
From: THIRD EYE CAPITAL CORPORATION
To: RESVERLOGIX CORP.
Reel/Frame 050763/0175 →
Assignment of Assignor's Interest
Mar 12, 2020
From: HANSEN, HENRIK C.; WAGNER, GREGORY S.; ATTWELL, SARAH C.; MCLURE, KEVIN G.
To: RESVERLOGIX CORP.
Reel/Frame 052101/0691 →
Release of Security Interest
Jan 12, 2021
From: VISION LEADER LIMITED
To: RESVERLOGIX CORP.
Reel/Frame 054888/0506 →
Security Interest
Jan 14, 2022
From: RESVERLOGIX CORP.
To: HEPALINK (HONG KONG) LIMITED
Reel/Frame 058655/0643 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 058655 Frame 0643. Assignor(S) Hereby Confirms the Security Interest.
Jan 27, 2022
From: RESVERLOGIX CORP.
To: HEPALINK (HONG KONG) LIMITED
Reel/Frame 058887/0288 →